Učitavanje...
Tumor mutation burden: from comprehensive mutational screening to the clinic
The recent advent of immunomodulatory therapies into the clinic has demanded the identification of innovative predictive biomarkers to identify patients most likely to respond to immunotherapy and support the design of tailored clinical trials. Current molecular testing for selection of patients wit...
Spremljeno u:
| Izdano u: | Cancer Cell Int |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6686509/ https://ncbi.nlm.nih.gov/pubmed/31406485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0929-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|